polysaccharide (o-deacetylated) neisseria meningitidis group c (strain c11)

Poland

Drugs containing this active substance

  • NEISVAC-C

    The vaccine is intended to prevent invasive meningococcal disease caused by group C bacteria, which can cause severe infections such as meningitis or septicaemia.

    Form: suspension for injection

    Active substance Dosage
    tetanus toxoid 10 - 20 mcg
    polysaccharide (o-deacetylated) neisseria meningitidis group c (strain c11) 10 mcg

    ATC: J07AH07

    Manufacturer: Pfizer Manufacturing Belgium NV